https://www.selleckchem.com/pr....oducts/z-4-hydroxyta
83 [0.77, 0.90], p 0.0001) and were significantly less likely to have recorded comorbidities. Raw in-hospital mortality was 1.8% for women and 4.1% for men. In the multivariable analysis of in-hospital mortality, the likelihood of death for women compared to men was 21% reduced (OR 0.79 [CI 0.66, 0.93, p = 0.005]). The risk of postoperative complications such as ventilation 48 h, ARDS, tracheotomy, or pneumonia was significantly lower for women. Women undergoing lung cancer surgery were younger and had less comorbi
Like
Comment
Share
